UnitedHealth Group Incorporated (UNH)[Tv]

Key Developments

• Berkshire Hathaway completed its full divestment of UnitedHealth Group (UNH) stake in Q1 2026, signaling a major institutional exit despite recent earnings momentum and operational improvements — a highly critical signal of deteriorating confidence among top-tier investors.
• The Office of Inspector General (OIG) released a damning report revealing Medicare Advantage post-hospital care denial rates at 51%–80%, far exceeding industry norms, marking a severe reputational and regulatory inflection point for UNH and undermining its narrative of responsible care delivery.
• Fairview Health Services announced it will no longer accept UNH Medicare plans, reflecting a tangible breakdown in provider trust and a direct threat to network integrity, with serious implications for operational sustainability and member retention.
• UNH launched a strategic review of its medical device division, highlighting internal struggles to sustain innovation outside Optum and raising concerns about long-term growth diversification and strategic focus.
• UNH secured broad coverage for Guardant Health’s FDA-approved Shield blood test for colorectal cancer screening across over 100 million Americans, cementing its role as a forward-thinking payer in preventive medicine and a key innovation milestone.

Critical News